Engineers Gate Manager’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$139K	Buy	29,477 +2,938	+11%	+$14.9K	﹤0.01%	1982
2025 Q4	$113K	Buy	+26,539	New	+$101K	﹤0.01%	1903
2023 Q1	–	Sell	-10,135	Closed	-$16.2K	–	1710
2022 Q4	$16.2K	Sell	10,135 -551	-5%	-$815	﹤0.01%	1611
2022 Q3	$15K	Sell	10,686 -16,928	-61%	-$26.1K	﹤0.01%	1543
2022 Q2	$51K	Buy	27,614 +90	+0.3%	+$172	﹤0.01%	1788
2022 Q1	$73K	Sell	27,524 -41,429	-60%	-$159K	﹤0.01%	1738
2021 Q4	$299K	Buy	+68,953	New	+$404K	0.01%	1411
2021 Q3	–	Sell	-55,035	Closed	-$348K	–	1698
2021 Q2	$348K	Buy	55,035 +25,535	+87%	+$199K	0.02%	1033
2021 Q1	$228K	Buy	+29,500	New	+$233K	0.01%	1515
2020 Q4	–	Sell	-28,409	Closed	-$189K	–	1742
2020 Q3	$189K	Sell	28,409 -17,577	-38%	-$130K	0.01%	1442
2020 Q2	$383K	Buy	45,986 +32,786	+248%	+$304K	0.02%	1088
2020 Q1	$101K	Buy	+13,200	New	+$92K	0.01%	1413